Evidence map›Paper›PMID 37735719›Full record

ArticleEmerging infectious diseases2023

Candida auris Clinical Isolates Associated with Outbreak in Neonatal Unit of Tertiary Academic Hospital, South Africa.

Dikeledi Kekana, Serisha D Naicker, Liliwe Shuping, Sithembiso Velaphi, Firdose L Nakwa, Jeannette Wadula, Nelesh P Govender, for GERMS-SA1

Open access · diamondAbstract read
In one paragraph

Article in Emerging infectious diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Prevalence, pattern of disease and antimicrobial susceptibility ofSouthern African journal of infectious diseases · 2026
    Article
  5. Decoding resistance inFrontiers in cellular and infection microbiology · 2026
    Article
  6. A Cross-Sectional Study to DetermineBioMed research international · 2026
    Article
  7. The rise ofEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2025
    Article
  8. mSphere · 2025
    Article
  9. First Report ofJournal of fungi (Basel, Switzerland) · 2025
    Article
  10. Neonatal Invasive Candidiasis: Current Concepts.Indian journal of pediatrics · 2025
    Review
  11. Review
  12. Observational
  13. Review
  14. Article
  15. The multidrug-resistantCurrent research in microbial sciences · 2025
    Review
  16. Neonatal Sepsis: A Comprehensive Review.Antibiotics (Basel, Switzerland) · 2024
    Review
  17. Article
  18. Current issues in molecular biology · 2024
    Review
  19. Open forum infectious diseases · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Dikeledi Kekana
Serisha D Naicker
Liliwe Shuping
Sithembiso Velaphi
Firdose L Nakwa
Jeannette Wadula
Nelesh P Govender
for GERMS-SA1
National Institute for Communicable DiseasesUniversity of Cape Town · ZAUniversity of Exeter · GBUniversity of the Witwatersrand · ZA

Funding

Southern African-Pittsburgh Public Health Genomic Epidemiology Training Program (SAPPHGenE)D43TW011255 · FIC · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Lee H Harrison, Anne von Gottberg · 2019 to 2026
$1.7M
FIC NIH HHS D43 TW011255
6 · The paper itself

Abstract

Candida auris was first detected at a university-affiliated hospital in Johannesburg, South Africa, in 2009. We used whole-genome sequencing to describe the molecular epidemiology of C. auris in the same hospital during 2016-2020; the neonatal unit had a persistent outbreak beginning in June 2019. Of 287 cases with culture-confirmed C. auris infection identified through laboratory surveillance, 207 (72%) had viable isolates and 188 (66%) were processed for whole-genome sequencing. Clade III (118/188, 63%) and IV (70/188, 37%) isolates co-circulated in the hospital. All 181/188 isolates that had a fluconazole MIC >32 µg/mL had ERG11 mutations; clade III isolates had VF125AL substitutions, and clade IV isolates had K177R/N335S/E343D substitutions. Dominated by clade III, the neonatal unit outbreak accounted for 32% (91/287) of all cases during the study period. The outbreak may have originated through transmission from infected or colonized patients, colonized healthcare workers, or contaminated equipment/environment.

Indexed as

Candida aurisDisease OutbreaksHospitals, UniversityHumansInfant, NewbornSouth AfricaTertiary Care Centersantifungal resistanceantimicrobial resistanceCandida aurisfungigenome analysispopulation geneticsSouth Africa

Identifiers

PMID37735719
PMCPMC10521600
OpenAlexW4386944332

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.